Edwards Lifesciences Stock: Likely To See Sluggish Price Action Through 2027
1. EW enters final Phase 18 of the Adhishthana cycle. 2. Sluggish, range-bound price action expected until early 2027. 3. No strong bullish indicators found in Guna Triads. 4. Previous high reached at $131, then significant decline observed. 5. Investors advised to consider range-bound strategies to mitigate volatility.